Loading...
935106861
info@markelab.com
Precio
387.5€ (100 µg)
Teplizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD3, This is anti-CD3 monoclonal antibody that is used in high-risk groups to prevent or delay the development of clinical type 1 diabetes (T1D). High-risk groups here refer to the presence of two or more T1D-related autoantibodies in the body.
Biosimilars
Human
Monoclonal
Human
CD3
Human
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 876387-05-2
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más